Table 2

- Frequencies and associations of demographics, clinical findings, and diagnosis with immunostaining (Ki67).

Parameters <25% (Very low) n=125%-50% (Low) n=551%-75% (Moderate) n=21>75% (High) n=16P-value
GenderFemale0 (0.0)4 (80.0)8 (38)9 (56.0)0.200
Male1 (100)1 (20.0)13 (62)7 (44.0)
Age group<500 (0.0)3 (60.0)3 (14)4 (25.0)0.572
50-600 (0.0)1 (20.0)6 (29)6 (37.0)
61-701 (100)1 (20.0)7 (33)3 (19.0)
>700 (0.0)0 (0.0)5 (24)3 (19.0)
H. pyloriNo1 (100)5 (100)14 (67)14 (87.5)0.352
Yes0 (0.0)0 (0.0)7 (33)2 (12.5)
Intestinal metaplasiaNo1 (100)5 (100)17 (81)14 (87.5)0.747
Yes0 (0.0)0 (0.0)4 (19)2 (12.5)
AnemiaNo0 (0.0)1 (20.0)5 (24)9 (56.0)0.129
Yes1 (100)4 (80.0)16 (76)7 (44.0)
Abdominal painNo0 (0.0)2 (40.0)3 (14)4 (25.0)0.424
Yes1 (100)3 (60.0)18 (86)12 (75.0)
SurgeryNo0 (0.0)1 (20.0)11 (52)5 (31.0)0.535
Yes1 (100)2 (40.0)6 (29)5 (31.0)
Unknown0 (0.0)2 (40.0)4 (19)6 (38.0)
ChemotherapyNo1 (100)2 (40.0)10 (48)5 (31.0)0.785
Yes0 (0.0)1 (20.0)7 (33)5 (31.0)
Unknown0 (0.0)2 (40.0)4 (19)6 (38.0)
Esophago-gastroduodenoscopyMass1 (100)2 (40.0)12 (57)10 (62.5)0.798
Ulcer0 (0.0)3 (60.0)7 (33.5)6 (37.5)
Unknown0 (0.0)0 (0.0)2 (9.5)0 (0.0)
MortalityAlive1 (100)0 (0.0)2 (9.5)8 (50.0)0.006**
Dead0 (0.0)5 (100)19 (90.5)8 (50.0)
Diagnoses of gastric cancer (% of diagnosis cases):
Intestinal type adenocarcinoma (n=6)Yes0 (0.0)0 (0.0)3 (50.0)3 (50.0)0.869
No1 (3)5 (13.5)18 (49)13 (35.0)
Signet ring cell adenocarcinoma (n=29)Yes0 (0.0)5 (17)16 (55)8 (28.0)0.054
No1 (7)0 (0.0)5 (36)8 (57.0)
Gastrointestinal stromal tumor (n=2)Yes1 (50.0)0 (0.0)1 (50.0)0 (0.0)0.058
No0 (0.0)5 (12)20 (49)16 (39)
Diffuse large B-cell lymphoma (n=5)Yes0 (0.0)0 (0.0)0 (0.0)5 (100)0.024*
No1 (3)5 (13)21 (55)11 (29)
MALToma (n=1)Yes0 (0.0)0 (0.0)1 (100)0 (0.0)> 0.05
No1 (2)5 (12)20 (48)16 (38)

Values are presented as numbers and percentages (%).

  • ↵** Significant at p<0.01.

  • ↵* Significant at p<0.05. P-value was calculated using Fisher’s exact test. Ten patients’ paraffin blocks were not available.